Stocks

Headlines

Eli Lilly Receives Strong Positive Rating from Guru Strategies

Eli Lilly achieves an impressive 88% with the P/B Growth Investor model, indicating solid growth metrics. This strong rating suggests high investor interest and potential upward movement in stock prices.

Date: 
AI Rating:   7

Investment Highlights for Eli Lilly

Eli Lilly and Co (LLY) has received an impressive 88% rating based on the P/B Growth Investor model attributed to Partha Mohanram. This growth model is designed to identify low book-to-market stocks that demonstrate potential for sustained future growth, highlighting Eli Lilly's strong fundamentals and favorable valuation. A rating above 80% indicates positive sentiment among investors.

The factors contributing to this high rating are summarized in the table provided. Eli Lilly has successfully passed various tests, demonstrating strength in key areas:

  • Book/Market Ratio: PASS
  • Return on Assets: PASS
  • Cash Flow from Operations to Assets: PASS
  • Cash Flow vs. Return on Assets: PASS
  • Sales Variance: PASS
  • Advertising to Assets: PASS
  • Capital Expenditures to Assets: PASS

However, it's worth noting that Eli Lilly did not pass the Research and Development to Assets test, which could be seen as a potential red flag for investors looking for innovation-driven growth. Nevertheless, the majority of its metrics indicate a financially healthy company poised for growth, thus enhancing investor confidence in LLY's stock.

Stocks:  LLY